Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 112 participants.
Also called NCT01135017
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 112 participants
- Sponsor
- Registry
-
NCT01135017
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT01135017. Randomized; triple masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2012-02 (actual). Results posted on 2013-04-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers
- Acronym
- HESTIA
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Dronedarone
- Intervention (Drug)
- Placebo (for Dronedarone)
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct01135017- Content hash
e233a2f06f7392f1ab72fedb94056ad94924a135136318d5b93f6ad742fddf09